APA (7th ed.) Citation

RW, E., MA, S., HI, E., SM, B., & SM, E. (2022). Thiazole-based SARS-CoV-2 protease (COV Mpro ) inhibitors: Design, synthesis, enzyme inhibition, and molecular modeling simulations. Archiv der Pharmazie, 355(9), e2200121. https://doi.org/10.1002/ardp.202200121

Chicago Style (17th ed.) Citation

RW, Elsayed, Sabry MA, El-Subbagh HI, Bayoumi SM, and El-Sayed SM. "Thiazole-based SARS-CoV-2 Protease (COV Mpro ) Inhibitors: Design, Synthesis, Enzyme Inhibition, and Molecular Modeling Simulations." Archiv Der Pharmazie 355, no. 9 (2022): e2200121. https://doi.org/10.1002/ardp.202200121.

MLA (9th ed.) Citation

RW, Elsayed, et al. "Thiazole-based SARS-CoV-2 Protease (COV Mpro ) Inhibitors: Design, Synthesis, Enzyme Inhibition, and Molecular Modeling Simulations." Archiv Der Pharmazie, vol. 355, no. 9, 2022, p. e2200121, https://doi.org/10.1002/ardp.202200121.